Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Richard Lindstrom

Ophthalmology Bloomington, MN Medical Doctor

NPI 1740275908 CMS profile 33129

9801 Dupont Ave S, Suite 200, Bloomington, MN 55431

Open in the dashboard

General payments

$5,648,677

338 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$8,856,505

16 holdings reported · through program year 2025

Through program year 2025, Richard Lindstrom of Bloomington, MN is reported in the CMS Open Payments database as having received $5,648,677 across 338 general payments and $0 in research payments paid to them. They also declared ownership or investment interests valued at $8,856,505 across 16 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 99th percentile of Ophthalmology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

14 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $965,580 32
2024 General $732,931 43
2023 General $969,690 45
2022 General $638,996 33
2021 General $848,291 50
2020 General $703,557 51
2019 General $789,633 84
2025 Ownership $3,334,019 1
2024 Ownership $2,741,616 2
2023 Ownership $1,098,106 2
2022 Ownership $842,735 3
2021 Ownership $621,871 4
2020 Ownership $138,195 2
2019 Ownership $79,963 2

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Richard Lindstrom
  • Ophthalmology median
  • Middle half of Ophthalmology
  • National median

In program year 2025, general payments to Richard Lindstrom were reported at $965,580. Among 13,034 Ophthalmology profiles paid that year, the median was $384 and the middle half received between $136 and $917.

Show as a table
Year Richard Lindstrom Ophthalmology median Middle half National median
2019 $789,633 $258 $104–$655 $163
2020 $703,557 $126 $45–$321 $114
2021 $848,291 $205 $76–$534 $132
2022 $638,996 $266 $100–$678 $149
2023 $969,690 $308 $117–$745 $160
2024 $732,931 $340 $127–$846 $164
2025 $965,580 $384 $136–$917 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Bausch & Lomb Americas Inc. $1,935,027 19 payments
  2. Ocular Therapeutix, Inc. $1,569,218 63 payments
  3. Bausch & Lomb, a division of Bausch Health US, LLC $1,331,494 14 payments
  4. Lensar, Inc. $322,861 34 payments
  5. TearLab Corp $198,855 24 payments
  6. Glaukos Corporation $77,637 30 payments
  7. Alcon Research LLC $54,699 18 payments
  8. Alcon Vision LLC $35,823 46 payments
  9. Harrow Eye, LLC $35,295 11 payments
  10. Johnson & Johnson Surgical Vision, Inc. $25,243 23 payments
  11. Other $62,526 56 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Royalty or License $3,285,776 28 payments
  2. Consulting Fee $1,297,967 134 payments
  3. Current or prospective ownership or investment interest $404,542 4 payments
  4. Honoraria $223,383 8 payments
  5. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $215,701 25 payments
  6. Grant $157,500 1 payment
  7. Travel and Lodging $50,513 28 payments
  8. Food and Beverage $12,957 108 payments
  9. Entertainment $250 1 payment
  10. Gift $89 1 payment
Products named General payments · program years 2019–2025
  1. OPHTHALMIC INSTRUMENTS $3,252,877 27 payments
  2. LENSAR LASER SYSTEM $322,861 34 payments
  3. DEXTENZA $160,479 19 payments
  4. TearLab Osmolarity System Medical Device $98,818 13 payments
  5. TearLab Osmolarity System Diagnostics $30,037 4 payments
  6. ScoutPro Osmolarity System $20,110 3 payments
  7. EYSUVIS $17,146 6 payments
  8. Tecnis Multifocal Family of 1-piece IOLS $16,487 8 payments
  9. Catalys Laser System $15,934 10 payments
  10. COMPACT INTUITIV Phacofragmentation System $15,610 5 payments
  11. Other $186,216 184 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Records

338 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Ophthalmology in Minnesota

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record